Myszkowski Kenneth Allen — SEC Form 4 filings

SEC reporting owner CIK 1486672. 2 Form 4 filings on record with FilingPulse; latest filed 2025-01-07.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-03-08 to 2025-01-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Chief Financial Officer25 legs · 85,167 sh · $2,300,6951

Form 4 filings — Myszkowski Kenneth Allen

FiledFormIssuerReported transactionsSource
2025-01-074ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Grant/award (A): 100,000 @ $0 · Sale (S): 17,765 @ $19.68 · Sale (S): 9,402 @ $20.10 · Sale (S): 8,000 @ $19.70 · Sale (S): 10,000 @ $19.69EDGAR
2024-03-084ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Sale (S): 40,000 @ $35.19EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1486672 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →